- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06470776
Chatbot Counselling for Smoking Cessation in Youths
November 17, 2025 updated by: Tzu Tsun Luk, The University of Hong Kong
Development of a Chatbot for Smoking Cessation Counselling for Youth Smokers Enrolled in the Youth Quitline: a Pilot Randomised Trial
The goal of this pilot trial is to develop and examine the trial feasibility and acceptability of a chatbot for smoking cessation in youth smokers. Specific aims include:
- To assess how many youth smokers accept the invitation to participate in the trial
- To assess the retention of the participants through 6 months after treatment initiation
- To assess the acceptability of the chatbot in terms of participants' compliance and usability rating of the chatbot.
- To estimate the intervention effect on abstinence outcomes
- To explore the participants' perception and experiences in the chatbot
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
154
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong, Hong Kong
- HKU Youth Quitline
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Hong Kong residents aged 25 years or younger
- Used a tobacco product in the past 30 days, including cigarettes, electronic cigarettes, heated tobacco products, etc.
- Able to communicate in Chinese
- Own a smartphone with internet access
Exclusion Criteria:
- Diagnosed with a mental disease or on regular psychotropic drugs, or
- Participating in other ongoing smoking cessation studies.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Chatbot counselling
Smoking cessation counselling delivered by chatbot
|
Access to a chatbot that provides smoking cessation counselling based on the 5A's (Ask, Advice, Assess, Assist, Arrange follow-up) and 5R's (Risk, Relevance, Rewards, Relevance, Roadblocks, Repetition) tobacco intervention models from baseline to 3-month post-baseline.
|
|
Active Comparator: Peer counselling
Smoking cessation counselling delivered by peer counsellors
|
Usual treatment provided by the Youth Quitline, i.e., telephone counselling for smoking cessation based on the 5As and 5Rs models delivered by trained peer counsellors at baseline and 1 week, 1 month and 3 months post-baseline
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biochemically-validated tobacco abstinence
Time Frame: 6 months after randomisation
|
Defined as a negative result of the iScreen OFD test for measuring salivary cotinine (with a cut-off of lower than 30ng/mL)
|
6 months after randomisation
|
|
Recruitment rate
Time Frame: Through recruitment completion, about 9 months
|
Number of participants divided by the number of eligible subjects
|
Through recruitment completion, about 9 months
|
|
Retention rate
Time Frame: 6 months
|
Number of participants completed the follow-up divided by the number of participants
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported 7-day point-prevalence tobacco abstinence
Time Frame: 3 months after randomisation
|
Being completely smoke-free in the past 7 days
|
3 months after randomisation
|
|
Self-reported 7-day point-prevalence tobacco abstinence
Time Frame: 6 months after randomisation
|
Being completely smoke-free in the past 7 days
|
6 months after randomisation
|
|
Self-reported 30-day point-prevalence tobacco abstinence
Time Frame: 3 months after randomisation
|
Being completely smoke-free in the past 30 days
|
3 months after randomisation
|
|
Self-reported 30-day point-prevalence tobacco abstinence
Time Frame: 6 months after randomisation
|
Being completely smoke-free in the past 30 days
|
6 months after randomisation
|
|
Self-reported 24-hour quit attempt
Time Frame: 3 months after randomisation
|
Serious attempt to quit smoking for 24 hours or longer in daily smokers
|
3 months after randomisation
|
|
Self-reported 24-hour quit attempt
Time Frame: 6 months after randomisation
|
Serious attempt to quit smoking for 24 hours or longer in daily smokers
|
6 months after randomisation
|
|
Self-reported 50% smoking reduction
Time Frame: 3 months after randomisation
|
Smoking reduction by at least half of the baseline daily number of cigarettes in continued smokers
|
3 months after randomisation
|
|
Self-reported 50% smoking reduction
Time Frame: 6 months after randomisation
|
Smoking reduction by at least half of the baseline daily number of cigarettes in continued smokers
|
6 months after randomisation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tzu Tsun Luk, PhD, RN, The University of Hong Kong
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 7, 2024
Primary Completion (Actual)
June 25, 2025
Study Completion (Actual)
June 25, 2025
Study Registration Dates
First Submitted
June 17, 2024
First Submitted That Met QC Criteria
June 17, 2024
First Posted (Actual)
June 24, 2024
Study Record Updates
Last Update Posted (Actual)
November 20, 2025
Last Update Submitted That Met QC Criteria
November 17, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20212551
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
The University of Hong KongCompletedSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
Clinical Trials on Chatbot counselling
-
National University of MalaysiaNot yet recruitingColorectal Cancer Screening | Bowel Preparation Quality | Colon Polyps and Adenomas | Artificial Intelligence (AI)Malaysia
-
Distrito Sanitario AlmeriaJunta de AndaluciaCompletedDigital Health | Workplace Violence | Health Professionals | ChatbotSpain
-
University of MinnesotaNational Institute on Minority Health and Health Disparities (NIMHD)Not yet recruiting
-
University of UtahAmerican Cancer Society, Inc.Recruiting
-
University of UtahHuntsman Cancer InstituteNot yet recruitingCancer | Financial ToxicityUnited States
-
University of Maryland, College ParkCompletedCervical Cancer | Anal Cancer | Penile CancerUnited States
-
University of California, IrvineNational Center for Complementary and Integrative Health (NCCIH)Not yet recruitingMajor Depressive Disorder | Generalized Anxiety Disorder (GAD)
-
Hong Kong Metropolitan UniversityRecruitingAutism Spectrum DisorderHong Kong
-
Cheng-Hsin General HospitalRecruitingLower Urinary Tract Symptoms | Erectile Dysfunction | Benign Prostate EnlargementTaiwan
-
Abramson Cancer Center at Penn MedicineActive, not recruitingHead and Neck Cancer | Lung Cancer | Gastrointestinal CancerUnited States